| 25-OCH3-PPD | 25-methoxy-protopanaxadiol |
| A20 | Tumor necrosis factor-α-induced protein 3 |
| AA | Arachidonic acid |
| AGS-H | Heat-processed American ginseng saponins |
| ALT | Alanine aminotransferase |
| AMPK | AMP-activated protein kinase |
| AP-1 | Activator protein-1 |
| ApoE | Apolipoprotein E |
| APPswe | Amyloid precursor protein Swedish mutation |
| ARE | Antioxidant response element |
| ASC | Apoptosis-associated speck-like protein containing a caspase recruitment domain |
| AST | Aspartate aminotransferase |
| ATP | Adenosine triphosphate |
| Bax | Bcl-2-associated x protein |
| Bcl-2 | B-cell lymphoma 2 |
| BDNF | Brain-derived neurotrophic factor |
| BMP-2 | Bone morphogenetic protein-2 |
| Brn-3a | Brain-specific homeobox/POU domain protein 3a |
| BUN | Blood urea nitrogen |
| C17SCV | C17 side-chain varied |
| cAMP | cyclic adenosine monophosphate |
| CD | Cluster of differentiation |
| c-Fos | c-Fos proto-oncogene |
| c-Jun | Cellular Jun proto-oncogen |
| c-Myc | Cellular myelocytomatosis oncogene |
| COL1A1 | Collagen type I alpha 1 |
| COVID-19 | Coronavirus disease 2019 |
| COX | Cyclooxygenase |
| cPLA2 | Cytosolic phospholipase A2 |
| CREB | cyclic adenosine monophosphate response element-binding protein |
| CYP3A4 | Cytochrome P450 3A4 |
| CYP450 | Cytochrome P450 |
| EC50 | Half maximal effective concentration |
| EGCG | Epigallocatechin-3-gallate |
| EMT | Epithelial to mesenchymal transition |
| eNOS | Endothelial nitric oxide synthase |
| ER | Endoplasmic reticulum |
| Egr-1 | Early growth response 1 |
| ERK | Extracellular signal-regulated kinase |
| FDA | Food and Drug Administration |
| Foxp3 | Forkhead box P3 |
| FUNDC1 | FUN14 domain containing 1 |
| GABA | Gamma-aminobutyric acid |
| G-CSF | Granulocyte colony-stimulating factor |
| GLS1 | Glutaminase 1 |
| Glu | Glutamate |
| GLUT1 | Glucose transporter 1 |
| GM1 | Monosialotetrahexosylganglioside 1 |
| GRAS | Generally recognized as safe |
| GSH | Glutathione |
| GTPase | Guanosine triphosphatase |
| GZMB | Granzyme B |
| HaCaT | Human keratinocyte |
| HDAC2 | Histone deacetylase 2 |
| HMGB1 | High mobility group box 1 |
| HO | Heme oxygenase |
| hP2X7 | Human P2X purinoceptor 7 |
| HSP70 | Heat shock protein 70 |
| IBD | Inflammatory bowel disease |
| IC50 | Half maximal inhibitory concentration |
| ICAM-1 | Intercellular adhesion molecule-1 |
| ICU | Intensive care unit |
| IDE | Insulin-degrading enzyme |
| IFN-γ | Interferon-gamma |
| Ig | Immunoglobulin |
| IGF-1 | Insulin-like growth factor-1 |
| IGF-1R | Insulin-like growth factor-1 receptor |
| IκBα | Inhibitor of nuclear factor kappa b alpha |
| IKKβ | Inhibitor of nuclear factor kappa b kinase subunit beta |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| JAK | Janus kinase |
| JNK | c-Jun N-terminal kinase |
| LOX-1 | Lectin-like oxidized low-density lipoprotein receptor-1 |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MD2 | Myeloid differentiation factor 2 |
| MDA | Malondialdehyde |
| MI/R | Myocardial ischemia/reperfusion |
| MIP-1δ | Macrophage inflammatory protein-1 delta |
| MMP | Matrix metalloproteinase |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MRL/lpr | Murphy Roths Large/lymphoproliferation |
| mTOR | Mammalian target of rapamycin |
| MW | Molecular weight |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NEP | Neprilysin |
| NETosis | neutrophil extracellular traps formation |
| NeuN | Neuronal nuclei |
| NFATc1 | Nuclear factor of activated T-cells, cytoplasmic 1 |
| NF-κB | Nuclear factor-kappa B |
| NGAL | Neutrophil gelatinase-associated lipocalin |
| NGF | Nerve growth factor |
| NK | Natural killer |
| NKG2D | Natural killer group 2 member D |
| NLC | Nanostructured lipid carrier |
| NLRP3 | Nucleotide-binding oligomerization domain-like receptor protein 3 |
| NMDA | N-methyl-D-aspartate |
| NOX1 | Nicotinamide adenine dinucleotide phosphate oxidase 1 |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| OA | Oleanolic acid |
| p-ACC | Phosphoacetyl-CoA carboxylase |
| PAM | Positive allosteric modulator |
| PCA | Passive cutaneous anaphylaxis |
| PD-L1 | Programmed death-ligand 1 |
| PEGylated | Polyethylene glycol-conjugated |
| PGE | Prostaglandin E |
| P-gp | P-glycoprotein |
| PI3K/AKT | Phosphatidylinositol 3-kinase/protein kinase B |
| PKC | Protein kinase C |
| PKCδ | Protein kinase C delta |
| PLA2 | Phospholipase A2 |
| PLCγ | Phospholipase Cγ |
| PLD | Phospholipase D |
| PPD | Protopanaxadiol |
| PPT | Protopanaxatriol |
| PSEFS | Peanut sprout extracts cultivated with fermented sawdust medium |
| PSEN1dE9 | presenilin 1 deletion of exon 9 |
| RANKL | Receptor activator of nuclear factor kappa-B ligand |
| RC50 | Half maximal response concentration |
| Rho | Ras homolog |
| RIP | Receptor-interacting protein |
| ROS | Reactive oxygen species |
| Runx2 | Runt-related transcription factor 2 |
| SAR | Structure–activity relationship |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| SIRT1 | Sirtuin 1 |
| Smad | Smad family proteins |
| SMEDDS | Self-microemulsifying drug delivery systems |
| SOD | Superoxide dismutase |
| STAT | Signal transducer and activator of transcription |
| Syk | Spleen tyrosine kinase |
| TAK1 | Transforming growth factor-beta-activated kinase 1 |
| t-BHP | Tertiary-butyl hydroperoxide |
| TGF-β1 | Transforming growth factor-β1 |
| Th | T helper |
| TLR4 | Toll-like receptor 4 |
| TME | Tumor microenvironment |
| TNBS | Trinitrobenzenesulfonic acid |
| TNF-α | Tumor necrosis factor alpha |
| ULK1 | Unc-51 like autophagy activating kinase 1 |
| UVB | Ultraviolet B |
| VEGF | Vascular endothelial growth factor |
| ZO-1 | Zonula occludens-1 |
| α-MSH | Alpha-melanocyte stimulating hormone |
| α-SMA | Alpha-smooth muscle actin |
| γδ T cells | Epidermal gamma delta T cells |